Interestingly, the NF-κB pathway is activated in CSF memory B cells from MS patients (108) and a mutation in the NFKB1 gene has been implicated in a primary immunodeficiency characterized by poor control of EBV and lymphoproliferation (109). Here, NFKB1 is linked to myeloid sarcoma.